Cargando…
External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes
AIMS/HYPOTHESIS: Treatment guidelines recommend the UK Prospective Diabetes Study (UKPDS) risk engine for predicting cardiovascular risk in patients with type 2 diabetes, although validation studies showed moderate performance. The methods used in these validation studies were diverse, however, and...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017299/ https://www.ncbi.nlm.nih.gov/pubmed/21076956 http://dx.doi.org/10.1007/s00125-010-1960-0 |
_version_ | 1782195892041809920 |
---|---|
author | van Dieren, S. Peelen, L. M. Nöthlings, U. van der Schouw, Y. T. Rutten, G. E. H. M. Spijkerman, A. M. W. van der A, D. L. Sluik, D. Boeing, H. Moons, K. G. M. Beulens, J. W. J. |
author_facet | van Dieren, S. Peelen, L. M. Nöthlings, U. van der Schouw, Y. T. Rutten, G. E. H. M. Spijkerman, A. M. W. van der A, D. L. Sluik, D. Boeing, H. Moons, K. G. M. Beulens, J. W. J. |
author_sort | van Dieren, S. |
collection | PubMed |
description | AIMS/HYPOTHESIS: Treatment guidelines recommend the UK Prospective Diabetes Study (UKPDS) risk engine for predicting cardiovascular risk in patients with type 2 diabetes, although validation studies showed moderate performance. The methods used in these validation studies were diverse, however, and sometimes insufficient. Hence, we assessed the discrimination and calibration of the UKPDS risk engine to predict 4, 5, 6 and 8 year cardiovascular risk in patients with type 2 diabetes. METHODS: The cohort included 1,622 patients with type 2 diabetes. During a mean follow-up of 8 years, patients were followed for incidence of CHD and cardiovascular disease (CVD). Discrimination and calibration were assessed for 4, 5, 6 and 8 year risk. Discrimination was examined using the c-statistic and calibration by visually inspecting calibration plots and calculating the Hosmer–Lemeshow χ(2) statistic. RESULTS: The UKPDS risk engine showed moderate to poor discrimination for both CHD and CVD (c-statistic of 0.66 for both 5 year CHD and CVD risks), and an overestimation of the risk (224% and 112%). The calibration of the UKPDS risk engine was slightly better for patients with type 2 diabetes who had been diagnosed with diabetes more than 10 years ago compared with patients diagnosed more recently, particularly for 4 and 5 year predicted CVD and CHD risks. Discrimination for these periods was still moderate to poor. CONCLUSIONS/INTERPRETATION: We observed that the UKPDS risk engine overestimates CHD and CVD risk. The discriminative ability of this model is moderate, irrespective of various subgroup analyses. To enhance the prediction of CVD in patients with type 2 diabetes, this model should be updated. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-010-1960-0) contains supplementary material, which is available to authorised users. |
format | Text |
id | pubmed-3017299 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-30172992011-02-04 External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes van Dieren, S. Peelen, L. M. Nöthlings, U. van der Schouw, Y. T. Rutten, G. E. H. M. Spijkerman, A. M. W. van der A, D. L. Sluik, D. Boeing, H. Moons, K. G. M. Beulens, J. W. J. Diabetologia Article AIMS/HYPOTHESIS: Treatment guidelines recommend the UK Prospective Diabetes Study (UKPDS) risk engine for predicting cardiovascular risk in patients with type 2 diabetes, although validation studies showed moderate performance. The methods used in these validation studies were diverse, however, and sometimes insufficient. Hence, we assessed the discrimination and calibration of the UKPDS risk engine to predict 4, 5, 6 and 8 year cardiovascular risk in patients with type 2 diabetes. METHODS: The cohort included 1,622 patients with type 2 diabetes. During a mean follow-up of 8 years, patients were followed for incidence of CHD and cardiovascular disease (CVD). Discrimination and calibration were assessed for 4, 5, 6 and 8 year risk. Discrimination was examined using the c-statistic and calibration by visually inspecting calibration plots and calculating the Hosmer–Lemeshow χ(2) statistic. RESULTS: The UKPDS risk engine showed moderate to poor discrimination for both CHD and CVD (c-statistic of 0.66 for both 5 year CHD and CVD risks), and an overestimation of the risk (224% and 112%). The calibration of the UKPDS risk engine was slightly better for patients with type 2 diabetes who had been diagnosed with diabetes more than 10 years ago compared with patients diagnosed more recently, particularly for 4 and 5 year predicted CVD and CHD risks. Discrimination for these periods was still moderate to poor. CONCLUSIONS/INTERPRETATION: We observed that the UKPDS risk engine overestimates CHD and CVD risk. The discriminative ability of this model is moderate, irrespective of various subgroup analyses. To enhance the prediction of CVD in patients with type 2 diabetes, this model should be updated. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-010-1960-0) contains supplementary material, which is available to authorised users. Springer-Verlag 2010-11-14 2011 /pmc/articles/PMC3017299/ /pubmed/21076956 http://dx.doi.org/10.1007/s00125-010-1960-0 Text en © The Author(s) 2010 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Article van Dieren, S. Peelen, L. M. Nöthlings, U. van der Schouw, Y. T. Rutten, G. E. H. M. Spijkerman, A. M. W. van der A, D. L. Sluik, D. Boeing, H. Moons, K. G. M. Beulens, J. W. J. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes |
title | External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes |
title_full | External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes |
title_fullStr | External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes |
title_full_unstemmed | External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes |
title_short | External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes |
title_sort | external validation of the uk prospective diabetes study (ukpds) risk engine in patients with type 2 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017299/ https://www.ncbi.nlm.nih.gov/pubmed/21076956 http://dx.doi.org/10.1007/s00125-010-1960-0 |
work_keys_str_mv | AT vandierens externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT peelenlm externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT nothlingsu externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT vanderschouwyt externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT ruttengehm externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT spijkermanamw externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT vanderadl externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT sluikd externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT boeingh externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT moonskgm externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes AT beulensjwj externalvalidationoftheukprospectivediabetesstudyukpdsriskengineinpatientswithtype2diabetes |